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Abstract. The separation and UV absorbance detection of colchicine by three different capillary electro-
phoretic methods is described. Colchicine is known as a neutral compound, being able to be determined 
by electrokinetic chromatography. For the first time, a non-aqueous capillary electrophoretic method is 
described, based on the electromigration of ionized colchicine induced by 10 mM HClO4 in a mixture of 
methanol:acetonitrile (1 :2, v/v) containing 60 mM ammonium formiate, opening up new perspectives in 
the trace analysis of the highly toxic drug from clinical and food samples using online coupling of the CE 
system to a mass spectrometer. For the quantitative assessment of colchicine content from meadow saf-
fron (Colchicum autumnale L.) seeds and 1 mg colchicine tablets, a simple, quick and sensitive micellar 
electrokinetic chromatographic method was developed and fully validated according to ICH guidelines in 
terms of selectivity, linearity, accuracy, intermediate precision and limits of detection and quantification 
(95.2 ng mL–1). In order to further improve the detection limits, allowing the analysis of trace levels of 
colchicine in biosamples and food products, an on-column preconcentration using sweeping-MEKC was 
investigated. Linearity of response was observed on 10–160 ng mL–1 colchicine, with an estimated detec-
tion limit of around 3 ng mL–1 colchicine. By further improving the affinity of the separation vector to-
wards colchicine this limit could be further decreased. Preliminary application of the method for the de-
tection of trace amounts of colchicine spiked in non-fat milk and human urine (10 ng mL–1) shows en-
couraging results. (doi: 10.5562/cca1765)  
Keywords: colchicine, capillary electrophoresis, NACE, MEKC, sweeping-MEKC  
Abbreviations: COL – colchicine; IS – internal standard; CE – capillary electrophoresis; DAD – diode ar-
ray detector; NACE – non-aqueous capillary electrophoresis; EOF – electroosmotic flow; SDS – sodium 
dodecyl sulfate; CZE – capillary zone electrophoresis; MEKC – micellar electrokinetic chromatography; 
MEEKC – microemulsion electrokinetic chromatography. 
 
INTRODUCTION 
Colchicine (Figure 1a), a toxic proto-alkaloid of mea-
dow saffron (Colchicum autumnale L., Colchicaceae) 
and flame lily (Gloriosa superba, Colchicaceae), is one 
of the oldest drugs used by the human kind, mainly in 
the treatment of autoinflammatory diseases and gout.1 
Colchicine has anti-inflammatory, anti-mitotic, and anti-
fibrotic activity.2 It also finds applications in various 
other diseases like pseudogout, familial Mediterranean 
fever, cirrhosis of the liver and bile, and amyloidosis.3 
Its mechanism of action is due to the specific interaction 
with tubulin, perturbing the assembly dynamics of mi-
crotubules.4 Therefore, besides its therapeutic value, its 
molecule is also an important tool in areas like plant 
amelioration (haploid plants), genetics and drug  
development.4–6 Hence, colchicine is a lead compound 
for the development of other potent anti-cancer drugs.  
Colchicine can also be ingested with non-
therapeutic purposes with other food products, inno-
cuously (e.g., in milk, via cattle and sheep grazing on 
alkaloid-producing plants, or veterinary use of colchi-
cine on cattle, accidental poisoning)7–9 or insidiously 
(e.g., intentional poisoning).10,11 
Due to its genotoxicity, even at low concentra-
tions, it could not be established for humans an accepta-
ble daily intake (ADI) of colchicine,12 and consequently 
it has been prohibited in livestock farming (Annex IV of 
European Council Regulation (EEC) No. 2377/90), 
because its residues in foodstuffs of animal origin  
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constitute a hazard to consumers health, whatever the 
limit. Moreover, the US Centers for Disease Control and  
Prevention included it on the list of biotoxins of concern 
in case of a chemical emergency.13 
Many studies have dealt with the development of 
separation techniques for the determination of colchi-
cine, based on TLC-densitometry,14,15 high performance 
liquid chromatography using UV 16–22 or MS detec-
tion.8,23–27 Nevertheless, highly sensitive electrochemi-
cal methods of quantification are also described,28–32 but 
their lack of selectivity hinders the analysis of complex 
matrixes (i.e. plant extracts, biological fluids and foods-
tuffs). 
Comparatively, only a few papers have been deal-
ing with the analysis of colchicine by electromigration 
techniques,13,33–35 amongst which two describing the use 
of microchip micellar electrokinetic chromatography. 
One of the major drawbacks of the described electro-
phoretic techniques, applied to clinical drug monitoring 
of colchicine, toxicological screening and food analysis, 
is their relatively high limit of detection and  
quantification (the lowest theoretical LOD reported is 
360 ng mL–1). 
As reported in literature, after a 2 mg single dose 
oral administration of colchicine the maximum mean 
plasmatic concentration (cmax) reached is around  
0.6 ng mL–1.36 Because of an enterohepatic cycle the 
bile/plasma concentration ratio of colchicine can rise up 
to 47.37 With therapeutic daily doses of 0.5–2.0 mg, 
plasma concentrations average 1 ng mL–1. Anything 
between 5–160 ng mL–1 colchicine in blood, falls into 
the toxic or lethal levels as it has been reported on sev-
eral fatal suicide cases, without being a clear correlation 
with the ingested drug.38 Moreover, while colchicine 
plasma levels have been retrospectively determined 
following a lethal ingestion, no clear correlation be-
tween plasma levels and outcome has been established, 
although death has followed a single oral ingestion of as 
little as 8 mg of colchicine.39 
Considering the above mentioned facts, the analy-
sis of trace levels of colchicine is imposed from a great 
number and variety of samples encountered in the fields 
of pharmaceutical, clinical, forensic, food and feedstuff 
industry. This demand puts an extra pressure in devel-
oping cost-effective, fast, sensitive, high performance 
and high throughput methods of analysis of minute 
amounts of the proto-alkaloid. 
 
EXPERIMENTAL 
Material and Methods 
Chemicals and Reagents 
Analytical grade colchicine (98 %) for biochemistry, 
sodium hydroxide, hydrochloric acid (37 % w/w), ace-
tonitrile, dichloromethane, isopropanol, acetone, petro-
leum ether, ethanol, methanol, SDS were all purchased 
from Merck, Germany. Boric acid, phosphoric acid  
(85 % w/w), ammonium formate (> 99 %), p-xylenol- 
sulfonephthalein were all purchased from Sigma Al-
drich. All mentioned reagents were used without any 
further treatment. Ultrapure water (18.2 MΩ, Barnstead 
EASYPure ROdi) was used for the preparation of buf-
fers and related aqueous solutions. Aqueous buffers at 
various pHs were prepared by dissolving the suitable 
electrolyte (phosphoric acid, boric acid) in ultrapure 
water and adjusting with NaOH (1 M) or HCl (1 M) 
with the aid of a pH-meter (Consort, Belgium). 
During sample preparation high purity nitrogen 
(5.0 purity, Linde Gaz Romania) was used for solvent 
evaporation. 
 
Reference and Sample Preparation 
The stock solutions of colchicine (1 mg mL–1) were 
freshly prepared in methanol each day and were stored 
in the dark. Each day aliquots of the stock solution were 
diluted in 10 mL volumetric flasks with water or organ-
ic solvent (NACE). 
Due to colchicine’s neutral behavior (pKa = 1.85 in 
water)40 and high solubility in water (measured  
logP = 1.30 41, estimated logP = 1.32 CSPredict soft-
ware, ChemSilico LLC 42) its sample extraction differ 
from those usually applied to alkaloids.43 Moreover, the 
nature of the sample matrix strongly affects the extrac-
tion technique. 
Vegetal samples (meadow saffron seeds) were 
prepared by Soxhlet extraction during 150 minutes 
using 95 % ethanol with an extraction ratio of 2.25 % 
m/v seeds/solvent. Before extraction, the seeds were 
defatted using petroleum ether, dried at room tempera-
ture and pulverized. 
The pharmaceutical samples were tablets with 
1mg declared amount of colchicine (Biofarm SA, Bu-
charest, Romania). After the determination of the aver-
age weight of tablets (0.1019 g), they were pulverized. 
A known amount of powder was transferred in a volu-
metric flask and adjusted to 10 mL with methanol. The 
colchicine was extracted by ultrasonication for 10 min 
and the suspension was then centrifuged for 3 min at 
5000 rpm. 
Figure 1. Structures of colchicines (a) and p-xylenolsulfo-
phthaleine (b). 
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The obtained extract or clear supernatant was ap-
propriately diluted with the running buffer or water and 
injected into the CE system for further MEKC analysis. 
Spiked skim (1.5 % fat) milk samples (10 ng mL–1 
colchicine) purchased from the local store (3 mL) were 
previously treated with HCl 37 % (12 µL HCl 37 % w/w 
to 1 mL milk) in order to free the bound colchicine and 
eliminate the most of fat and proteins.44 After centrifu-
gation (5 min at 5000 rpm) the supernatant was ex- 
tracted by liquid-liquid extraction using dichlorome-
thane:isopropanol (95:5, v/v) in a ratio of 3:10 sam-
ple/organic solvent mixture. The obtained organic phase 
was evaporated over dry N2 and the residue was  
dissolved in an appropriate volume of micelle-free  
high conductivity buffer (100 mM phosphate buffer  
pH = 4.0), added to match the conductivity of the  
running buffer. 
Spiked human urine samples (10 ng mL–1 colchi-
cine) from healthy voluntaries were simply diluted  
with a micelle-free buffer (20 mM phosphate buffer  
pH = 4.0), and filtered before being injected into the CE 
system. 
In sweeping-MEKC separations, each sample was 
spiked with 80 ng mL–1 p-xylenolsulfonephthalein as an 
internal standard. 
 
Instrumentation and Method Description 
Method development and analytical measurements were 
carried out on an Agilent 3D CE system (Agilent Tech-
nologies, Waldbronn, Germany). The CE system was 
equipped with a diode-array detector, the capillary being 
thermostated by air-cooling. Data acquisition was carried 
out by 3D-CE Chemstation Rev. A.08.03(843). Detection 
wavelengths in all cases were 243 and 350 nm, bandwith 
of 30 nm. Both CZE and MEKC were performed using 
bare fused-silica capillaries (50 m I.D., L = 64.5 cm,  
l = 56 cm, with extended light path (B.F = 3), Agilent 
Technologies, Germany). 
The new capillary was pre-conditioned prior to use 
by flushing successively with 1.0 M sodium hydroxide for 
20 min, 0.1 M sodium hydroxide for 20 min, de-ionized 
water for 20 min, and running buffer for 20 min. 
At the beginning of the day the capillary was pre-
conditioned with 0.1 M NaOH, water and running buffer 
each for 10 minutes in regular sequence. Between runs the 
capillary was flushed with running buffer for 3 minutes. In 
case of NACE, the same pre-conditioning protocol was 
applied, employing methanolic solutions of NaOH (1 M 
and 0.1 M) and pure methanol. 
For aqueous CZE separations 25 mM phosphate 
buffer (pH = 2.50 and pH = 1.30 adjusted with HCl 1 M) 
and for MEKC 10 mM borate buffer (pH = 9.30) with  
25 mM sodium dodecylsulphate with no organic modifier 
was used. Prior the analysis, all buffers and samples were 
passed through a 0.45 m pore-sized syringe filter 
(SPARTAN 13, Whatman GmbH, Germany). Samples 
were loaded by hydrodynamic injection (250 mbar·s). 
Throughout all the analysis the capillary was thermostated 
at 20 °C (if not otherwise mentioned), applying a separa-
tion potential of +30 kV (465 V/cm) (if not otherwise 
mentioned) with a short linear ramp between 0 to 0.3 
minutes. 
Sweeping-MEKC was performed at 50 oC in near-
zero EOF conditions created by a 5 minute flush of the 
capillary with HCl 0.1 M before every 8th–10th analysis. 
An 88.5 cm long (80 cm effective length, i.d. 50 µm, 
Polymicro Technologies, Germany) uncoated fused 
silica capillary with a BGE of phosphate buffer (20 mM, 
pH = 4) containing 3% (v/v) acetonitrile and 50 mM 
SDS. Samples were injected at the cathode by pressure 
(washing mode, 930 mbar, 36 s) and analyzed at –30 kV 
(reversed polarity). Throughout the separation a linear 
gradient (0–10 min) of 10 mbar pressure was applied 
from the inlet-end of the capillary. 
 
RESULTS AND DISCUSSION 
Aqueous and Non-aqueous Capillary Zone Electro-
phoresis 
Unlike other alkaloids, colchicine behaves as a neutral 
compound, it is highly soluble in water, and regardless 
of the pH of the aqueous buffer it migrates with the 
electroosmotic flow. Using 25 mM phosphate buffer 
(pH = 2.50) a single peak at 4.47 minutes is detected 
corresponding to the co-eluted peaks of colchicine and 
solvent. Further lowering the pH of the running buffer 
to 1.30, the ionization of colchicine is still not observed 
and the co-eluted peak shows a higher migration time 
(12 minutes) due the further decrease of the EOF  
mobility. 
Figure 2. Non-aqueous capillary zone electrophoresis using
10 mM HClO4 with 60 mM HCOONH4 in methanol : acetoni-
trile (1:2, v/v), bare fused silica capillary (L = 64.5 cm, i.d. 50
µm), 20 kV, 25 °C, hydrodynamic injection, detection 243
nm; Sample: colchicine and acetone (as a neutral EOF marker)
in the running buffer. 
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The chemical and physical properties of organic 
solvents are different from that of water, which could 
change the pKa value of the solute and the radius of its 
hydration shell, thus non-aqueous capillary electropho-
resis (NACE) could be used to improve separation se-
lectivity of compounds if they are difficult to be ana-
lyzed in aqueous systems. Since, the ratio of the proto-
nated and neutral forms of a very weak basic drug in an 
acidic, but totally non-aqueous medium may be smaller; 
the extent of electroosmotic flow is therefore expected 
to have a significant influence on colchicine’s apparent 
mobility in such a medium. The nature of non-aqueous 
solvents proves to be critical in NACE. These solvents 
having a large value of dielectric constant/viscosity (ε/η) 
ratio could give rise to appreciable electroosmotic mo-
bilities. In this regard, acetonitrile, with a dielectric 
constant of 37.5 and a viscosity of 0.34 mPa s, has  
perhaps the most favourable ε/η value (110 mPa–1 s–l), 
even higher than that for water (78.5 mPa–1 s–l). Other 
organic solvents having high ε/η values are acetone  
(69 mPa–1 s–l) and methanol (59 mPa–1 s–l).45 Since in 
pure acetonitrile the solubility of electrolytes can be 
troublesome, as solvent for non-aqueous capillary elec-
trophoretic separations, a mixture of methanol-
acetonitrile was considered. Furthermore, as described 
in the literature, the fastest EOF is given by a mixture of 
approximatively 25–30 %, v/v methanol in acetonitrile, 
containing amonium acetate as electrolyte.45,46 There-
fore, in the following NACE assays a mixture of 1:2 v/v, 
methanol in acetonitrile was used as solvent. Ammo-
nium formate (60 mM) was the chosen as electrolyte, 
whereas several organic and inorganic acids were added 
into the running buffer with the aim of influencing the 
ionization of colchicine. The molecule of colchicine 
could not be ionized by formic acid and trifluoroacetic 
acid added to the running buffer, whereas perchloric 
acid, at a reasonably low concentration (10 mM) al-
lowed the determination of colchicine by NACE-CZE. 
The different electrophoretic behavior of colchicine in 
the presence of perchloric acid compared with other 
strong acids was attributed to an ion pairing effect, in-
stead of a simple protonation due to the added acids. 
Perchloric acid acts as a strong electrolyte even in pure 
acetonitrile and thus can be considered fully dissociated 
in the used running buffer. The electroosmotic mobility 
(3.3 · 10–4 cm2 V–1 s–1) was determined by injecting 
acetone as a neutral EOF marker, the peaks being identi-
fied based on their known UV spectra (Figure 2).  
Table 1. Separation parameters of colchicine by micellar electrokinetic chromatography without and with on column preconcen-
tration  
 MEKC Sweeping-MEKC 
Capillary 
Bare fused silica with extended light path 
(B.F.= 3) L = 64.5 cm, l = 56 cm, i.d. 50 µm 
Bare fused silica L = 88.5 cm, l = 80 cm, 
i.d. 50 µm 
Preconditioning in between runs Flushing 3 minutes with the running buffer 
Running buffer 
10 mM borate buffer (pH = 9.3) with  
25 mM SDS 
20 mM phosphate buffer (pH = 4) with  
50 mM SDS and 3 % v/v acetonitrile 
Temperature 20 °C 50 °C 
Separation potential 30 kV (465 V/cm) –30 kV (339 V/cm) 
Separation pressure – 10 mbar (0 – 10 minute linear gradient) 
Sample injection (% of the total 
capillary volume) 
Hydrodynamic 250 mbar·s  
(0.54 %; ~5.92 nL) 
Hydrodynamic 33480 mbar·s  
(60.93 %; ~1059 nL) 
Detection 243/30 nm and 350/30 nm 
Linear range 200 – 2000 ng mL–1 10 – 160 ng mL–1 
Limit of detection 31.41 ng mL–1 2.84 ng mL–1 
Colchicine’s migration time 
7.64 min 
(RSD = 2.5 %, n = 10) 
10.73 min 
(RSD = 2.10 %, n = 10) 
Total analysis time 11 mina 18 mina 
(a) capillary preconditioning comprised. 
Table 2. Linear regression parameters and its statistical evalu-
ation 
Parameters 
200 – 2500 ng mL–1, 
Injection 250 mbar·s  





Intercept –0.0196 ± 0.0034a  
Slope 0.000357 ± 0.000011a  
Cochran’s test
Comparative 
test of the  
homogeneity of 
variances
Ccalc. = 0.496 Ctheor 




Fcalc. = 6516.26 Ftheor 
(0.05;1;13) = 4.67 Fcalc. > Ftheor. 
Fisher’s test
Validity of  
regression
Fcalc.= –2.71 Ftheor 
(0.05;3;10) = 3.71 Fcalc. < Ftheor. 
(a) standard deviation (n=3). 
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Even though the described NACE method 
represents an absolute novelty in the CE analysis of 
colchicine, with the standard UV detection setup, it still 
does not allow the analysis of minute amounts of  
protoalkaloid from biological samples.  
 
Micellar Electrokinetic Chromatography 
Method Development 
A 10 mM boric acid adjusted to the desired pH with 1 
M NaOH was selected as running buffer. Since, in the 
most common working pH range (pH = 2–12), colchi-
cine’s ionization in aqueous solutions can not be signifi-
cantly influenced by the pH of the buffer, its value has 
been set at pH = 9.30, this pH offering a conveniently 
high EOF (5.88 · 10–4 cm2 V–1 s–1) and consequently 
shorter migration time of the solute. 
Based on linear solvation energy relationships, 
surfactant concentration could influence retention beha-
vior of uncharged solutes by changing the phase ratio 
without significantly affecting selectivity.47 The selec-
tivity offered by sodium dodecyl sulfate (strong hydro-
gen-bond acid) was appropriate and by increasing its 
concentration only results in general increase of reten-
tion and a decrease of UV detection sensitivity, without 
any improvement on separation. Therefore, a concentra-
tion of 25 mM SDS was chosen as the optimized condi-
tion, since both resolution and peak shape were accept-
able. The final, separation parameters are summarized 
in Table 1. 
 
MEKC Method Validation 
The proposed method was validated according to ICH 
guidelines 48 in terms of specificity, linearity, accuracy 
and precision. Furthermore, as an estimation of the 
method’s analytical performance, limits of detection and 
quantification were also calculated. 
On each of the three consecutive days of valida-
tion, five calibration standards in the range of  
200–2500 ng mL–1 colchicine were employed. Three 
sets of five control samples were also prepared from 
individual weightings and stored in dark. The standard 
and control samples were injected hydrodynamically at 
250 mbar·s (~ 5.64 nL). The detection and quantification 
was done at 243 nm. The recorded average migration 
time for colchicine in the optimized separation condi-
tions was 7.64 minutes, with a relative standard devia-
tion in the range of 0.53–2.5 %. 
Specificity. The specificity of the method was assessed 
based on the obtained migration times and peak purity 
analysis offered by the DAD detector. In case of the 
pharmaceutical sample analysis, the assay of placebo 
samples assured the lack of any interference. 
Linearity. Using the corrected areas (= peak area / mi-
gration time) of colchicine’s peaks recorded at 243 nm a 
five leveled regression curve was constructed. The re-
gression parameters and its statistical evaluation are 
presented in Table 2. 
 
Accuracy. The method’s accuracy was assessed on five 
independent control samples, prepared in three different 
days, being statistically evaluated by the comparative 
test of homogeneity of variances (Cochran’s test) and 
the validity of average recovery (Fisher’s test)  
(Table 3). 
 
Precision. Intermediate precision was established based 
on the obtained recoveries of six independently 
weighted control samples at the lower limit of linear 
range (200 ng mL–1) on three different series prepared in 
three different days. The obtained data was statistically 
evaluated, its values being summarized in Table 4. 
 
Limits of Detection and Quantification. The limits of 
detection (LOD) and quantification (LOQ) were calcu-
lated as (3.3 σ/S) and (10 σ/S), respectively, where σ is 
the standard deviation of the intercepts and S is the 
slope of the calibration curve. The calculated LOD and 
LOQ were found to be 31.41 ng mL–1 and  
95.20 ng mL–1, respectively. 
The validated MEKC method was successfully 
applied to the quantification of colchicine from meadow 
saffron (Colchicum autumnale L.) seeds and tablets  
Table 3. Statistical evaluation of method’s accuracy 




 Nominal/  ng mL–1 
 
 Recovery/ % 
 200 104.95 
 400 97.00 
 800 100.97 
 1600 99.59 
 2400 99.87 
Mean recovery/%  100.47 
Cochran’s test
(Ccalc. < Ctheor.)









interval (p = 0.05)
 100.47 ± 2.84% 
 
Table 4. Statistical evaluation of the intermediate precision 
(k = 3, n = 6, N = 18) 
Parameters 200 ng mL–1  
Cochran’s test
Comparative test of the homo-
geneity of variances intra-group 
Ccalc. = 0.472
Ctheor(0.05;3;6) = 0.677 
(Ccalc. < Ctheor.)
Intra-day precision (CVr) 4.84% 
Inter-day precision (CVR) 6.35% 
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(1 mg colchicine, Biofarm S.A., Bucharest) (Figure 3). 
The sample extraction and pretreatment was carried out 
according to method described at Section 2.2. The col-
chicine content of Colchicum seeds and pharmaceutical 
sample content uniformity (per tablet) are summarized 
in Table 5, which are in compliance with the Romanian 
Pharmacopeia’s normative (±10 %).49 
Although the analytical performances of the pre-
sented MEKC method are remarkable, it is still limited 
to samples with a concentration of around 100 ng mL–1 
colchicine. Therefore, pharmaceutical samples (tablets, 
injectable solutions) and plant extracts (aerial and un-
derground parts) can be successfully analyzed, but is 
improper for the quantitative determination of trace 
amounts of the proto-alkaloid found in biological sam-
ples (urine, plasma) or as a residue in food and feed-
stuffs. Therefore, the efficiency of different on-column 
preconcentration techniques by sample stacking with 
reverse migrating vector (i.e. micelles)50 in micellar 
electrokinetic chromatography was investigated. 
In these conditions, from the cathodic end of the 
capillary, a large volume of micelle free sample (having 
a similar conductivity with the background electrolyte) 
is injected hydrodynamically. The capillary was pre-
viously preconditioned with the micellar running buffer, 
making sure that the EOF is completely suppressed. 
Both ends of the capillary are introduced into the micel-
lar background solution and the separation voltage is 
applied with the negative polarity at the injection end. In 
the lack of a significant electroosmotic flow the nega-
tively charged micelles on their way through the sample 
zone, towards the detection end of the capillary, sweep 
up the neutral analytes, stacking them in narrow bands 
and that are finally separated by normal MEKC. The pH 
of the sample and the running buffer must be kept the 
lowest possible, avoiding the generation of unwanted 
EOF, without compromising the solubility of the surfac-
tant. The effectiveness of the stacking is dependent on 
the analyte’s affinity towards the micelles, the higher 
affinity the larger the extent of stacking. 
Near-zero EOF conditions could be obtained by 
decreasing the zeta potential of the capillary’s inner wall 
double-layer by an acid pretreatment. Due to the pH 
hysteresis effect, the re-equilibration of the surface 
charge on the fused silica appears to be a slow process 
and the silanol groups’ dissociation may take several 
weeks at intermediate pH.51,52 Therefore, the bare fused 
silica capillaries were flushed at the beginning of the 
day for 15 minutes by 0.1 M HCl and this acid pre-
treatment step has been repeated for 5 minutes at every 
8th–10th analysis, assuring a near-zero EOF during all 
subsequent assays. The running buffer was set to  
pH = 4, its composition being optimized for the best 
signal to noise ratio and highest resolution of colchicine. 
Since there is no electroosomotic flow capable of 
maintaining the “plug” flow in the bubble cell, using 
this separation technique, there is no boost of sensitivity 
offered by the capillaries with an extended light path. 
Instead of an axial compression of the separated frac-
tions entering the detection cell, the solutes are diluted 
in the expanded capillary, resulting in lower signals 
compared with the ones obtained by the same length of 
a normal capillary. Therefore, for the highest sample 
load and separation efficiency, a long bare fused silica 
capillary (L = 88.5 cm, l = 80 cm, 50 µm i.d.) was used 
with a total inner volume of 1.737 µL. 
Considering the highest gain in sensitivity, best 
resolution and the shortest analysis time, different com-
positions of the background electrolyte were tested, 
finally arriving to 50 mM SDS in 20 mM phosphate 
buffer (pH = 4) with a content of 3 % (v/v) acetonitrile. 
The optimum running parameters are presented in Table 
1. The organic modifier was added to the running buffer 
for the improvement of resolution between the peaks of 
the added internal standard and colchicine. 
Even though the injected sample volume in 
sweeping-MEKC is almost 180-fold higher than in 
simple MEKC, the gain in sensitivity is somewhat less 
(around 20 fold) due to the relatively high hydrophilici-
ty of colchicine. The obtained lower limit of the linear 
range (10 ng mL–1) is already the lowest ever reported 
for colchicine by an electromigration method. 
Figure 3. MEKC electropherograms for the quantitative assay
of colchicine from vegetal extracts and pharmaceutical sam-
ples; 10 mM borate buffer (pH = 9.30) with 25 mM SDS, bare
fused silica capillary (L = 64.5 cm, i.d. 50 µm, B.F. = 3),
30 kV, 20 °C, hydrodynamic injection 250 mbar·s, detection
243 nm; 1 – colchicine tablets extract; 2 – standard colchicine
(50 µg mL–1); 3 – Colchicum autumnale L. seeds extract
sample. 
Table 5. Colchicine determination through different electro-
migration techniques 
Samples (n = 3) Aqueous MEKC 
Colchicine tablets, 1 mg 
Biofarm S.A. Bucharest (mg/tablet) 0.939 ± 0.005 
Colchicum autumnale seeds, 
Soxhlet extraction (g/100 g seeds) 
0.511 ± 0.012 
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The long time taken (670 s) for the high sample 
volume load at the highest hydrodynamic pressure in-
jection (50 mbar) allowed by the Agilent 3D-CE system 
can be overcame by flushing the capillary with the sam-
ple for 36 s with at 930 mbar. The evaluation of the 
obtained regression parameters by the two forms of 
sample injection demonstrated the lack of any statisti-
cally significant difference. However, for the assurance 
of the sample injection reproducibility and the method’s 
accuracy, p-xylenolsulfonephthalein (p-xylenol blue, 
Figure 1b) as internal standard must be employed (Table 
6). The internal standard was chosen according to its 
matching polarity with colchicine and its pKa value  
(pKa = 2.0), making sure that it is not a naturally occur-
ring compound in the studied samples (vegetal extracts, 
urine and milk). Therefore, p-xylenolsulfonephthalein is 
in its non-dissociated form at the pH of the running 
buffer and is swept along by the SDS micelles similarily 
as colchicine. 
For the further improvement of the analysis time, 
when most of the sample focalization has been carried 
out, an external pressure was applied on inlet end of  
the capillary (linear gradient to 10 mbar, between  
0–10 minutes). Therefore, the full analysis time of col-
chicine using on-column sample preconcentration by 
Sweeping-MEKC was achieved in less than 18 minutes, 
with an estimated limit of detection of 2.84 ng mL–1. 
The developed sweeping-MEKC method was 
tested for the determination of colchicine from spiked 
urine and skimmed milk samples (10 ng mL–1 colchi-
cine) (Figure 4). Using the given parameters, none of 
the real samples of skimmed milk (1.5 % fat) purchased 
from the local store contained traces of colchicine. Fur-
thermore, urine of healthy voluntaries was spiked with 
standard colchicine for the assessment of recovery  
(96.3–101.4 %, n = 5). In function of the nature of the 
sample matrix and the used pre-treatment changes in 
colchicine’s migration times are observed, therefore 
regression must be assessed by using calibration sam-
ples prepared in the analyzed matrix free of colchicine. 
 
CONCLUSION 
The performance, perspectives and limitations of three 
different electromigration techniques for the quantita-
tive determination of colchicine from vegetal, pharma-
ceutical, food and biological fluid samples was eva-
luated. 
For the first time, the separation of colchicine as a 
charged molecule was described employing non-
Table 6. Statistical evaluation of the two types of hydrodynamic sample injections in sweeping-MEKC 
Hydrodynamic sample injection at 50 mbar for 670 s Hydrodynamic sample injection by flushing at 930 mbar for 
36 s, with the use of IS 
3 series of 5 levels of concentration (intra-day assays)










0.0071454 0.048484 0.9963  0.012996 0.066698 0.9986 
Average recovery/ %  96.4  Average recovery/ %  99.3 
R.S.D. of recovery/ %  11.9  R.S.D. of recovery/ %  5.7 
Comparative test of 
variances intra-group 
Ctheor(0,05;5;2) = 0,68 
 Ccalc = 0.601  
Comparative test of 
variances intra-group 
Ctheor(0,05;5;2) = 0,68
 Ccalc = 0.629 
Confidence limits of the 
average recovery/ %  96.42 ± 6.04  
Confidence limits of the 
average recovery/ %  99.35 ± 4.18 
 
Figure 4. Sweeping-MEKC electropherograms for the quan-
titative assay of colchicine from spiked skimmed milk (A) and
healthy human urine (B); 20 mM phosphate buffer (pH = 4)
with 50 mM SDS, bare fused silica capillary (L = 88.5 cm,
l = 80 cm, i.d. 50 µm), –30 kV, 10 mbar pressure linear gra-
dient 0 – 10 min, hydrodynamic injection 33480 mbar·s,
detection 243/30 nm; IS – p-xylenolsulfonephthalein. 
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aqueous capillary electrophoresis. This technique opens 
up new perspectives in the trace analysis of the highly 
toxic drug from clinical and food samples; using vo- 
latile buffer additives, without the need of any pseudo-
stationary phase (surfactants in MEKC) capable of  
inducing strong ion-suppression, therefore allowing  
the online coupling of the CE system to a mass spec-
trometer.  
A validated, sensitive method by micellar electro-
kinetic chromatography was developed for the quantita-
tion of colchicine from meadow saffron seeds (Colchi-
cum autumnale L.) collected from the surroundings of 
Cluj-Napoca, Romania, the main natural source of the 
proto-alkaloid. Furthermore, passing a full validation, it 
proves to be a valuable tool for the industrial pharmacy 
in the quality control and content uniformity assays. 
However, the main drawback of the proposed 
MEKC method as well as of those few capillary and 
microchip electrophoretic methods presented in the 
literature is their limited sensitivity, which hinders their 
use in the in clinical drug monitoring, toxicological 
screening and food analysis (residues). Therefore, de-
veloping a fast and highly sensitive electromigration 
technique with an on-column preconcentration was 
attempted, using sweeping micellar electrokinetic chro-
matography. Even though the preconcentration efficien-
cy is not at its maximum value using SDS micelles, the 
preliminary results show a limit of detection of around  
3 ng mL–1 colchicine, the lowest ever reported by capil-
lary electrophoresis according to our knowledge. By 
further improving the retention factor of the separation 
vector (mixed-micelles or microemulsion) this limit 
could be further decreased, allowing the quantification 
of trace levels of colchicine in biological fluids or food 
products. Preliminary application of the method for the 
detection of trace amounts of colchicine spiked in skim 
milk and human urine (10 ng mL–1) shows encouraging 
results. 
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